相关实验视频
Updated: Sep 17, 2025
07:15
An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
2.6K
皮肤冠状动脉干预后缺血性心肌病患者的临床表型
Daisuke Nakamura1, Isamu Mizote1, Tomoharu Dohi1
1Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
概括
潜在类分析在接受皮肤冠状动脉干预 (PCI) 的患者中发现了三种不同的缺血性心肌病变 (ICM) 表型. 现型2显示死亡率和心力衰竭住院风险明显降低,建议针对ICM亚型进行量身定制的治疗.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 临床研究 临床研究
背景情况:
- 穿皮冠状动脉干预 (PCI) 是一种治疗选择,用于患有缺血性心肌病 (ICM) 的患者,这些患者有很高的手术风险.
- 在ICM中PCI的有效性受到争议,可能是由于病情的异质性.
- 潜在类分析 (LCA) 可以根据临床特征识别不同的患者子组.
研究的目的:
- 使用隐性类分析 (LCA) 描述缺血性心肌病 (ICM) 现象型.
- 评估临床结果,包括死亡率和心力衰竭住院治疗,通过皮肤冠状动脉干预 (PCI) 后识别的ICM表型.
- 探索左心室逆向重塑 (LVRR) 在不同ICM表型中的作用.
主要方法:
- 隐性类分析 (LCA) 应用于492名患者的临床数据,其左心室喷射率<50%,这些患者接受了PCI.
- 主要结局是全因死亡率和心力衰竭 (HF) 住院治疗.
- 表型的特征是临床特征,结果在不同组之间进行了比较.
主要成果:
- 确定了三种不同的ICM表型.
- 现象型1:严重的慢性病,血液透析 (n=101). 现象型2:男性,早期开始的ICM,生活方式疾病,高BMI (n=192). 现象型3:年长的成年人,心房动,心肌吐,高BNP (n=199).
- 现型2显著降低了联合死亡率和HF住院风险. LVRR仅在表型3中与更好的结果相关.
结论:
- 在PCI后的ICM表型中存在不同的临床结果和LVRR模式.
- 这些发现表明基础机制在ICM表型之间有所不同.
- 针对特定ICM表型的个性化治疗策略可能会改善结果.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
64
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
64
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
50
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
50
01:25Cardiomyopathy I: Introduction and Classification
71
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
71
01:29Cardiomyopathy V: Interprofessional Care
40
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
40
01:30Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26